Latest Articles
Teacher shares her incredible fight against endometrial adenocarcinoma, a cancer of the reproductive syst - Times of India
Teacher shares her incredible fight against endometrial adenocarcinoma, a cancer of the reproductive syst Times of India
Published: Jan. 21, 2026, 3:17 p.m.
Teacher shares her incredible fight against endometrial adenocarcinoma, a cancer of the reproductive syst - The Times of India
Teacher shares her incredible fight against endometrial adenocarcinoma, a cancer of the reproductive syst The Times of India
Published: Jan. 21, 2026, 8:06 a.m.
Mendelian randomization analysis of PKD1 in endometrial cancer and comparative multi-cancer study with renal cell carcinoma - springermedicine.com
Mendelian randomization analysis of PKD1 in endometrial cancer and comparative multi-cancer study with renal cell carcinoma springermedicine.com
Published: Jan. 14, 2026, 6:02 a.m.
Deep learning-based automated detection of endometrioid endometrial carcinoma in histopathology - Frontiers
Deep learning-based automated detection of endometrioid endometrial carcinoma in histopathology Frontiers
Published: Dec. 8, 2025, 10:41 a.m.
A rare curious case of ureteric dissection in a patient with vaginal vault recurrence of endometrial carcinoma - SpringerOpen
A rare curious case of ureteric dissection in a patient with vaginal vault recurrence of endometrial carcinoma SpringerOpen
Published: Nov. 25, 2025, 8:52 a.m.
Peritoneal Inclusion Cyst Mimicking Peritoneal Carcinomatosis: A Benign Lesion Posing a Malignant Dilemma - Cureus
Peritoneal Inclusion Cyst Mimicking Peritoneal Carcinomatosis: A Benign Lesion Posing a Malignant Dilemma Cureus
Published: Nov. 20, 2025, 6:22 a.m.
FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma - 뉴스와이어
FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma 뉴스와이어
Published: Nov. 13, 2025, 5:50 a.m.
FDA Clears New CDx for Pembrolizumab/Lenvatinib in Endometrial Carcinoma - Targeted Oncology
FDA Clears New CDx for Pembrolizumab/Lenvatinib in Endometrial Carcinoma Targeted Oncology
Published: Nov. 12, 2025, 7:08 p.m.
FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma - BioSpace
FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma BioSpace
Published: Nov. 12, 2025, 4:01 a.m.
Hysterectomy Status and Outcomes in Patients With Grade 1, Stage IA Endometrioid Adenocarcinoma - 2 Minute Medicine
Hysterectomy Status and Outcomes in Patients With Grade 1, Stage IA Endometrioid Adenocarcinoma 2 Minute Medicine
Published: Nov. 12, 2025, 12:07 a.m.
Link copied to clipboard!